JNJ

238.71

-0.54%↓

UNH

277.86

+0.52%↑

TMO

542.43

+0.07%↑

ABT

110.77

-0.05%↓

ISRG

493.16

+1.21%↑

JNJ

238.71

-0.54%↓

UNH

277.86

+0.52%↑

TMO

542.43

+0.07%↑

ABT

110.77

-0.05%↓

ISRG

493.16

+1.21%↑

JNJ

238.71

-0.54%↓

UNH

277.86

+0.52%↑

TMO

542.43

+0.07%↑

ABT

110.77

-0.05%↓

ISRG

493.16

+1.21%↑

JNJ

238.71

-0.54%↓

UNH

277.86

+0.52%↑

TMO

542.43

+0.07%↑

ABT

110.77

-0.05%↓

ISRG

493.16

+1.21%↑

JNJ

238.71

-0.54%↓

UNH

277.86

+0.52%↑

TMO

542.43

+0.07%↑

ABT

110.77

-0.05%↓

ISRG

493.16

+1.21%↑

Home・Aktien・Celsion Corp

Celsion Corp

Open

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

Max

Schlüsselkennzahlen
By Trading Economics
Angestellte	25

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+465.75% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	938K
Vorheriger Eröffnungskurs	0
Vorheriger Schlusskurs	0

Celsion Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Feb. 2026, 23:57 UTC

Market Talk

Uranium Outlook Heats Up on Rising Demand, Uncertain Supply -- Market Talk

8. Feb. 2026, 23:47 UTC

Market Talk

Gold Rises Amid Growing U.S.-Iran Tensions -- Market Talk

8. Feb. 2026, 23:43 UTC

Market Talk

Nikkei Likely to Rise Sharply After Takaichi's Election Win -- Market Talk

8. Feb. 2026, 23:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. Feb. 2026, 23:34 UTC

Market Talk

Landslide Election Victory of Japan's LDP Positive for Risk Assets -- Market Talk

8. Feb. 2026, 23:26 UTC

Market Talk

Yen Skittish; Nikkei Jumps On LDP Landslide -- Market Talk

8. Feb. 2026, 22:55 UTC

Ergebnisse

DBS Group 4Q Net S$2.36B Vs. Net S$2.62B >D05.SG

8. Feb. 2026, 22:55 UTC

Ergebnisse

DBS Group 4Q Net Interest Income S$3.59B Vs. S$3.83B>D05.SG

8. Feb. 2026, 22:55 UTC

Ergebnisse

DBS Board Proposes 4Q Dividend of 66 Singapore Cents/share>D05.SG

8. Feb. 2026, 22:55 UTC

Ergebnisse

DBS Group: 2025 Total Dividend at S$3.06/share >D05.SG

8. Feb. 2026, 22:55 UTC

Ergebnisse

DBS Group 4Q Net Weighed by Higher Tax Expense, Absence of Non-Recurring Gains Recrorded Last Year >D05.SG

8. Feb. 2026, 22:55 UTC

Ergebnisse

DBS Group 4Q Total Income S$5.33B Vs. S$5.51B>D05.SG

8. Feb. 2026, 21:43 UTC

Market Talk

FX Intervention Watch Resumes After Japan Election Result -- Market Talk

8. Feb. 2026, 21:16 UTC

Market Talk

Right Of Australian Politics Reshaped as One Nation Surges -- Market Talk

8. Feb. 2026, 21:15 UTC

Market Talk

Japan's Election Outcome to Revive Takaichi Trade -- Market Talk

7. Feb. 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7. Feb. 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

7. Feb. 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7. Feb. 2026, 02:46 UTC

Akquisitionen, Fusionen, Übernahmen

Big Money, High Anxiety -- Barrons.com

6. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. Feb. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

6. Feb. 2026, 21:40 UTC

Akquisitionen, Fusionen, Übernahmen

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6. Feb. 2026, 21:22 UTC

Market Talk

Mexico's Inflation Seen Accelerating in January -- Market Talk

6. Feb. 2026, 21:17 UTC

Ergebnisse

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6. Feb. 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. Feb. 2026, 21:14 UTC

Akquisitionen, Fusionen, Übernahmen

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6. Feb. 2026, 21:13 UTC

Ergebnisse

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6. Feb. 2026, 21:13 UTC

Ergebnisse

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6. Feb. 2026, 21:04 UTC

Market Talk

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6. Feb. 2026, 20:34 UTC

Ergebnisse

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

Peer-Vergleich

Kursveränderung

Celsion Corp Prognose

Kursziel

By TipRanks

465.75% Vorteil

12-Monats-Prognose

Durchschnitt 18.5 USD 465.75%

Hoch 25 USD

Tief 12 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Celsion Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Celsion Corp – Dist abgegeben haben.

Finanzen

Über Celsion Corp

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.